✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Supriya Lifescience Ltd.

SUPRIYA

Market Cap
₹5,775 Cr.
P/E
33.10

Supriya Lifescience Ltd.

  • Supriya Lifescience
  • AMI Organics
  • Aether Industries
  • TJI Pharma - API & CRAMS
FAQs on Supriya Lifescience Ltd. Shareprice

Supriya Lifescience has given better returns compared to its competitors.
Supriya Lifescience has grown at ~78.7% over the last 2yrs while peers have grown at a median rate of 43.94%

Yes, Supriya Lifescience is expensive.
Latest PE of Supriya Lifescience is 33.1, while 3 year average PE is 24.45.
Also latest EV/EBITDA of Supriya Lifescience is 22.88 while 3yr average is 15.37.

View FAQ's On Business
Growth Table
  • Supriya Lifescience Ltd.
  • AMI Organics
  • Aether Industries
Balance Sheet
  • Supriya Lifescience Ltd.
  • AMI Organics
  • Aether Industries
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Supriya Lifescience Ltd.
  • AMI Organics
  • Aether Industries
Cash Flow
  • Supriya Lifescience Ltd.
  • AMI Organics
  • Aether Industries
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Supriya Lifescience Ltd.
  • AMI Organics
  • Aether Industries
Quarterly Results
  • Supriya Lifescience Ltd.
  • AMI Organics
  • Aether Industries
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Supriya Lifescience Ltd. Financials

Balance sheet of Supriya Lifescience is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Supriya Lifescience is increasing.
Latest debt of Supriya Lifescience is -₹84.31 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹149.85 Crs.

Yes, profit is increasing.
The profit of Supriya Lifescience is ₹175 Crs for TTM, ₹119 Crs for Mar 2024 and ₹89.86 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Supriya Lifescience latest dividend payout ratio is 5.41% and 3yr average dividend payout ratio is 4.65%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech